1. Home
  2. ABP vs FCUV Comparison

ABP vs FCUV Comparison

Compare ABP & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • FCUV
  • Stock Information
  • Founded
  • ABP 2004
  • FCUV 2012
  • Country
  • ABP United States
  • FCUV United States
  • Employees
  • ABP N/A
  • FCUV N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • FCUV Industrial Machinery/Components
  • Sector
  • ABP Health Care
  • FCUV Industrials
  • Exchange
  • ABP Nasdaq
  • FCUV Nasdaq
  • Market Cap
  • ABP 17.2M
  • FCUV 15.9M
  • IPO Year
  • ABP N/A
  • FCUV N/A
  • Fundamental
  • Price
  • ABP $0.19
  • FCUV N/A
  • Analyst Decision
  • ABP Strong Buy
  • FCUV
  • Analyst Count
  • ABP 1
  • FCUV 0
  • Target Price
  • ABP $4.00
  • FCUV N/A
  • AVG Volume (30 Days)
  • ABP 5.0M
  • FCUV 43.3K
  • Earning Date
  • ABP 11-18-2025
  • FCUV 11-06-2025
  • Dividend Yield
  • ABP N/A
  • FCUV N/A
  • EPS Growth
  • ABP N/A
  • FCUV N/A
  • EPS
  • ABP N/A
  • FCUV N/A
  • Revenue
  • ABP $183,000.00
  • FCUV $432,983.00
  • Revenue This Year
  • ABP N/A
  • FCUV N/A
  • Revenue Next Year
  • ABP N/A
  • FCUV N/A
  • P/E Ratio
  • ABP N/A
  • FCUV N/A
  • Revenue Growth
  • ABP 154.17
  • FCUV 140.82
  • 52 Week Low
  • ABP $0.15
  • FCUV $1.80
  • 52 Week High
  • ABP $11.19
  • FCUV $10.90
  • Technical
  • Relative Strength Index (RSI)
  • ABP 43.91
  • FCUV 64.83
  • Support Level
  • ABP $0.19
  • FCUV $3.36
  • Resistance Level
  • ABP $0.21
  • FCUV $3.34
  • Average True Range (ATR)
  • ABP 0.02
  • FCUV 0.37
  • MACD
  • ABP -0.00
  • FCUV 0.10
  • Stochastic Oscillator
  • ABP 14.12
  • FCUV 62.14

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

Share on Social Networks: